Context Therapeutics Inc.
NASDAQ:CNTXBiotechnology
Healthcare
$0.69 +2.93%
+$0.02 today
- Market cap
- $63.67M
- Beta
- 1.61
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$0.42
52W Low $0.56High $3.62
Volume 1.71M
Average 1.16M
Price history
Context Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-40.77%
Period high
$3.36
Period low
$0.55
Latest
$0.69
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 8-K | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 4 | Jun 26, 2026 | Jun 26, 2026 | |
| 8-K | Jun 15, 2026 | Jun 15, 2026 | |
| 8-K | May 18, 2026 | May 18, 2026 | |
| SC 13G/A | May 15, 2026 | May 15, 2026 | |
| SC 13G/A | May 14, 2026 | May 14, 2026 | |
| SC 13G | May 14, 2026 | May 14, 2026 | |
| SC 13G/A | May 12, 2026 | May 12, 2026 | |
| SC 13G/A | May 8, 2026 | May 8, 2026 | |
| 10-Q | May 6, 2026 | May 6, 2026 |
Competitors
Who does Context Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CNTX's filings, answered from its disclosures.
What is the latest CNTX filing?
The latest filing shown is 4 dated Jun 26, 2026.
How many recent filings does CNTX have?
Intrinsic Alpha currently shows 20 recent filings for CNTX.
Continue the stock analysis
Jump to another research area for this company.